Stammdaten
Unternehmen
| Name | Mineralys Therapeutics, Inc. |
|---|---|
| Ticker | MLYS |
| CIK | 0001933414 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Mineralys Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:35:49.684891 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -417 | 25.65 | -10,696.05 | -0,5% | |
| 2026-03-17 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -417 | 25.65 | -10,696.05 | -0,5% | |
| 2026-03-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -253 | 27.82 | -7,038.46 | -0,3% | |
| 2026-03-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -253 | 27.82 | -7,038.46 | -0,3% | |
| 2026-03-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -10,726 | 25.91 | -277,922.46 | -13,4% | |
| 2026-03-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -3,079 | 27.37 | -84,264.53 | -4,1% | |
| 2026-03-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -10,726 | 25.91 | -277,922.46 | -13,4% | |
| 2026-03-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -3,079 | 27.37 | -84,264.53 | -4,1% | |
| 2026-03-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -6,348 | 27.37 | -173,747.93 | -8,4% | |
| 2026-03-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -6,348 | 27.37 | -173,747.93 | -8,4% | |
| 2026-03-09 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,171 | 26.84 | -58,269.64 | -2,8% | |
| 2026-02-17 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -417 | 27.59 | -11,505.03 | -0,6% | |
| 2026-02-17 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -417 | 27.59 | -11,505.03 | -0,6% | |
| 2026-02-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -4,166 | 27.33 | -113,856.78 | -5,5% | |
| 2026-02-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -3,541 | 27.33 | -96,775.53 | -4,7% | |
| 2026-02-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -6,348 | 27.58 | -175,100.06 | -8,4% | |
| 2026-02-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -4,166 | 27.33 | -113,856.78 | -5,5% | |
| 2026-02-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -3,541 | 27.33 | -96,775.53 | -4,7% | |
| 2026-02-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -6,348 | 27.58 | -175,100.06 | -8,4% | |
| 2026-02-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -5,828 | 28.94 | -168,634.93 | -8,1% | |
| 2026-02-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -521 | 29.64 | -15,441.76 | -0,7% | |
| 2026-02-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -5,828 | 28.94 | -168,634.93 | -8,1% | |
| 2026-02-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -521 | 29.64 | -15,441.76 | -0,7% | |
| 2026-02-09 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,171 | 30.21 | -65,585.91 | -3,2% | |
| 2026-02-09 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,171 | 30.21 | -65,585.91 | -3,2% | |
| 2026-01-20 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -416 | 32.10 | -13,353.60 | -0,6% | |
| 2026-01-20 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -416 | 32.10 | -13,353.60 | -0,6% | |
| 2026-01-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,367 | 32.61 | -370,644.91 | -17,8% | |
| 2026-01-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,367 | 32.61 | -370,644.91 | -17,8% | |
| 2026-01-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -7,709 | 32.75 | -252,469.75 | -12,1% | |
| 2026-01-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -7,709 | 32.75 | -252,469.75 | -12,1% | |
| 2026-01-12 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -7,117 | 33.15 | -235,932.11 | -11,3% | |
| 2026-01-12 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -10,758 | 32.14 | -345,723.39 | -16,6% | |
| 2026-01-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -6,348 | 32.32 | -205,143.24 | -9,9% | |
| 2026-01-12 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -6,348 | 32.32 | -205,143.24 | -9,9% | |
| 2026-01-12 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -9,119 | 32.21 | -293,707.49 | -14,1% | |
| 2026-01-09 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,170 | 33.27 | -72,195.90 | -3,5% | |
| 2026-01-09 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,170 | 33.27 | -72,195.90 | -3,5% | |
| 2026-01-05 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -53,470 | 35.53 | -1,899,553.83 | -91,3% | |
| 2026-01-05 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -139,245 | 34.83 | -4,849,555.24 | -233,1% | |
| 2026-01-05 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -53,470 | 35.53 | -1,899,553.83 | -91,3% | |
| 2026-01-05 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -139,245 | 34.83 | -4,849,555.24 | -233,1% | |
| 2026-01-02 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -70,037 | 35.87 | -2,511,919.03 | -120,8% | |
| 2026-01-02 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -70,037 | 35.87 | -2,511,919.03 | -120,8% | |
| 2025-11-20 | Slingsby Brian Taylor | Director, 10% Owner | Open Market Sale | -1,000,000 | 43.35 | -43,350,000.00 | -2084,0% | |
| 2025-11-13 | Karydas Daphne | Director | Open Market Sale | -4,885 | 46.36 | -226,446.13 | -10,9% | |
| 2025-11-13 | Gold Alexander M | Director | Open Market Sale | -12,742 | 46.50 | -592,503.00 | -28,5% | |
| 2025-11-13 | Karydas Daphne | Director | Open Market Sale | -10,115 | 45.81 | -463,350.95 | -22,3% | |
| 2025-11-12 | Gold Alexander M | Director | Open Market Sale | -5,000 | 46.50 | -232,500.00 | -11,2% | |
| 2025-11-12 | Gold Alexander M | Director | Open Market Sale | -1,933 | 47.28 | -91,385.67 | -4,4% | |
| 2025-11-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -12,806 | 41.64 | -533,235.44 | -25,6% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -1,015 | 42.00 | -42,630.00 | -2,0% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -11,295 | 41.87 | -472,931.82 | -22,7% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -1,561 | 42.68 | -66,622.54 | -3,2% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -12,952 | 41.65 | -539,479.29 | -25,9% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -8,485 | 42.34 | -359,258.29 | -17,3% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -4,142 | 43.50 | -180,183.21 | -8,7% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -8,456 | 45.18 | -382,046.31 | -18,4% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -38,900 | 45.93 | -1,786,587.53 | -85,9% | |
| 2025-11-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -32,718 | 46.88 | -1,533,976.89 | -73,7% | |
| 2025-11-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -8,862 | 42.31 | -374,946.79 | -18,0% | |
| 2025-11-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -4,000 | 43.50 | -173,983.60 | -8,4% | |
| 2025-11-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -29,207 | 45.20 | -1,320,165.16 | -63,5% | |
| 2025-11-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -112,275 | 45.83 | -5,145,956.21 | -247,4% | |
| 2025-11-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -32,850 | 46.89 | -1,540,211.67 | -74,0% | |
| 2025-11-11 | Gold Alexander M | Director | Open Market Sale | -10,000 | 42.43 | -424,298.00 | -20,4% | |
| 2025-11-11 | Gold Alexander M | Director | Open Market Sale | -5,000 | 47.08 | -235,408.00 | -11,3% | |
| 2025-10-15 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -10,369 | 43.01 | -445,982.10 | -21,4% | |
| 2025-10-15 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -10,369 | 43.01 | -445,982.10 | -21,4% | |
| 2025-10-13 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -3,392 | 42.26 | -143,332.69 | -6,9% | |
| 2025-10-13 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -13,548 | 42.63 | -577,544.47 | -27,8% | |
| 2025-10-13 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -1,552 | 43.03 | -66,782.40 | -3,2% | |
| 2025-10-13 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -7,366 | 41.90 | -308,650.87 | -14,8% | |
| 2025-09-15 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -9,302 | 35.90 | -333,945.52 | -16,1% | |
| 2025-09-15 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -9,302 | 35.90 | -333,945.52 | -16,1% | |
| 2025-09-15 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,065 | 36.47 | -75,320.46 | -3,6% | |
| 2025-09-15 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,065 | 36.47 | -75,320.46 | -3,6% | |
| 2025-09-04 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 588,235 | 25.50 | 14,999,992.50 | +721,1% | |
| 2025-09-04 | RA CAPITAL MANAGEMENT, L.P. | Director | Open Market Purchase | 1,176,470 | 25.50 | 29,999,985.00 | +1442,2% | |
| 2025-09-04 | RA CAPITAL MANAGEMENT, L.P. | Director | Open Market Purchase | 1,176,470 | 25.50 | 29,999,985.00 | +1442,2% | |
| 2025-09-04 | RA CAPITAL MANAGEMENT, L.P. | Director | Open Market Purchase | 1,176,470 | 25.50 | 29,999,985.00 | +1442,2% | |
| 2025-09-04 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 588,235 | 25.50 | 14,999,992.50 | +721,1% | |
| 2025-09-04 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 588,235 | 25.50 | 14,999,992.50 | +721,1% | |
| 2025-08-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,365 | 12.93 | -146,986.95 | -7,1% | |
| 2025-08-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,365 | 12.93 | -146,986.95 | -7,1% | |
| 2025-07-30 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -8,425 | 15.10 | -127,203.18 | -6,1% | |
| 2025-07-30 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -51,500 | 14.70 | -757,168.45 | -36,4% | |
| 2025-07-29 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -807 | 14.00 | -11,301.87 | -0,5% | |
| 2025-07-28 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -12,946 | 14.04 | -181,803.27 | -8,7% | |
| 2025-07-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,366 | 14.59 | -165,878.81 | -8,0% | |
| 2025-07-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,366 | 14.59 | -165,878.81 | -8,0% | |
| 2025-07-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -15,884 | 14.51 | -230,430.78 | -11,1% | |
| 2025-07-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -10,758 | 14.45 | -155,454.18 | -7,5% | |
| 2025-06-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,366 | 14.60 | -165,931.10 | -8,0% | |
| 2025-06-13 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,366 | 14.60 | -165,931.10 | -8,0% | |
| 2025-05-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,366 | 15.29 | -173,773.64 | -8,4% | |
| 2025-05-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -11,366 | 15.29 | -173,773.64 | -8,4% | |
| 2025-04-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -8,400 | 14.83 | -124,572.00 | -6,0% | |
| 2025-04-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,966 | 13.69 | -40,613.14 | -2,0% | |
| 2025-04-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -8,400 | 14.83 | -124,572.00 | -6,0% | |
| 2025-04-14 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,966 | 13.69 | -40,613.14 | -2,0% | |
| 2025-04-11 | Congleton Jon | Director, Officer, Chief Executive Officer | Open Market Sale | -15,319 | 12.19 | -186,802.95 | -9,0% | |
| 2025-04-11 | Levy Adam Scott | Officer, CFO and Secretary | Open Market Sale | -10,757 | 12.06 | -129,684.24 | -6,2% | |
| 2025-04-01 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -22,406 | 16.77 | -375,748.62 | -18,1% | |
| 2025-04-01 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -30,574 | 15.00 | -458,542.74 | -22,0% | |
| 2025-04-01 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -22,406 | 16.77 | -375,748.62 | -18,1% | |
| 2025-04-01 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,791 | 16.02 | -44,717.12 | -2,1% | |
| 2025-04-01 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -30,574 | 15.00 | -458,542.74 | -22,0% | |
| 2025-04-01 | Rodman David Malcom | Officer, Chief Medical Officer | Open Market Sale | -2,791 | 16.02 | -44,717.12 | -2,1% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.